Hedge Fund Titans Bet Big on Drugmaker Shire’s Success

John Paulson, Dan Loeb, and other prominent Investors move into an industry in flux.

December 8, 2016


	Illustration by Renaud Vigor.

For the past few years, Shire has been defined by two things: popular niche drugs and failed M&A.

To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.

Lone Pine Capital Shire John Paulson Dan Loeb Suvretta Capital Management Marshall Wace Hedge Fund

Premium

November 30, 2023

Premium

November 29, 2023